A PROSPECTIVE NON-INTERVENTIONAL SAFETY STUDY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING NILOTINIB IN DAILY PRACTICE ACCORDING TO UPDATED GUIDELINES

21/01/2013
02/07/2024
EU PAS number:
EUPAS3335
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

CAMN107AAT01_Tasigna_PASS_Protocol_version01_Redacted

English (512.23 KB - PDF) View document
Study results
Study results

CAMN107AAT01_Redacted CSR

English (612.58 KB - PDF) View document
Study report
Other information